Henoch-Schönlein purpura nephritis in children: Risk factors, prevention and treatment

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 12, 2009, Pages 1882-1889

  Bogdanović, Radovan ^a  

^a Institute of Mother and Child Healthcare of Serbia Dr Vukan upi   (Serbia)

Author keywords

Children; Henoch; Prevention; Risk factors; Sch nlein purpura nephritis; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BLOOD CLOTTING FACTOR 13; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYPROHEPTADINE; DIPYRIDAMOLE; HEPARIN; HYDROCORTISONE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; UROKINASE; WARFARIN;

ABDOMINAL DISEASE; ANAPHYLACTOID PURPURA; CLINICAL TRIAL; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; GLOMERULUS; HENOCH SCHONLEIN PURPURA NEPHRITIS; HUMAN; NEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; TREATMENT OUTCOME;

CHILD; HUMANS; NEPHRITIS; PURPURA, SCHOENLEIN-HENOCH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 71049122323     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01445.x     Document Type: Review

References (60)

1. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002 360 : 1197 1202.
2. Stewart M, Savage JM, Bell B, McCord B. Long term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population. Eur J Pediatr 1988 147 : 113 115.
3. Rostoker G. Schönlein-Henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs 2001 15 : 99 138.
4. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005 90 : 916 920.
5. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/Pres endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheumatol Dis 2006 65 : 936 941.
6. Coppo R, Amore A Henoch-Schonlein purpura. In : Avner ED, Harmon WE, Niaudet P, editors. Pediatric nephrology. 5th ed. Baltimore, MD : Lippincott Williams & Wilkins, 2004 : 851 863.
7. Koskimies O, Mir S, Rapola J, Vilska J. Henoch-Schönlein nephritis: long-term prognosis of unselected patients. Arch Dis Child 1981 56 : 482 484.
8. Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 1992 339 : 280 282.
9. Schärer K, Kramar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schönlein-Henoch purpura nephritis in children. Pediatr Nephrol 1999 13 : 816 823.
10. Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP. Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura. Nephrol Dial Transplant 1997 12 : 2277 2283.
11. Butani L, Morgenstern BZ. Long-term outcome in children after Henoch-Schonlein purpura nephritis. Clin Pediatr (Phila) 2007 46 : 505 511.
12. Kaku Y, Nohara K, Honda S. Renal involvement in Henoch-Schonlein purpura: a multivariate analysis of prognostic factors. Kidney Int 1998 53 : 1755 1759.
13. Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch-Schonlein purpura. Eur J Pediatr 2002 161 : 196 201.
14. Rigante D, Candelli M, Federico G, Bartolozzi F, Porri MG, Stabile A. Predictive factors of renal involvement or relapsing disease in children with Henoch-Schonlein purpura. Rheumatol Int 2005 25 : 45 8.
15. Shin JI, Park JM, Shin YH, Hwang DH, Kim JH, Lee JS. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schönlein purpura. Scand J Rheumatol 2006 35 : 56 60.
16. de Almeida JL, Campos LM, Paim LB, Leone C, Koch VH, Silva CA. Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of initial prognostic factors. J Pediatr (Rio J) 2007 83 : 259 266.
17. Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005 35 : 143 153.
18. Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, et al. Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 2006 149 : 241 247.
19. White RHR, Yoshikawa N, Feehaly J IgA nephropathy and Henoch-Schonlein nephritis. In : Barratt TM, Avner ED, Harmon WE, editors. Pediatric nephrology. 4th ed. Baltimore, MD : Lippincott Williams & Wilkins, 1998 : 691 706.
20. Rieu P, Noel L-H. Henoch-Schonlein nephritis in children and adults. Morphological features and clinicopathological correlations. Ann Med Interne 1999 150 : 151 158.
21. Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study. Lancet 2002 360 : 666 670.
22. Bunchman TE, Mauer SM, Sibley RK, Vernier RL. Anaphylactoid purpura: characteristics of 16 patients who progressed to renal failure. Pediatr Nephrol 1988 2 : 393 397.
23. Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, et al. Predictors of outcome in Henoch-Schönlein nephritis in children and adults. Am J Kidney Dis 2006 47 : 993 1003.
24. Mir S, Yavascan O, Mutlubas F, Yeniay B, Sonmez F. Clinical outcome in children with Henoch-Schönlein nephritis. Pediatr Nephrol 2007 22 : 64 70.
25. Algoet C, Proesmans W. Renal biopsy 2-9 years after Henoch Schonlein purpura. Pediatr Nephrol 2003 18 : 471 473.
26. Weiss PF, Feinstein JA, Luan X, Burnharm JM, Feudtner C. Effects of corticosteroid on Henoch-Schonlein purpura: a systematic review. Pediatrics 2007 120 : 1079 1087.
27. Buchanec J, Galanda V, Belakova S, Minarik M, Zibolen M. Incidence of renal complications in Schonlein-Henoch purpura syndrome in dependence of an early administration of steroids. Int Urol Nephrol 1988 20 : 409 412.
28. Saulsbury FT. Corticosteroid therapy does not prevent nephritis in Henoch-Schönlein purpura. Pediatr Nephrol 1993 7 : 69 71.
29. Saulsbury FT. Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 1999 78 : 395 409.
30. Reinehr T, Burk G, Andler W. Does steroid treatment of abdominal pain prevent renal involvement in Henoch-Schnlein purpura? J Pediatr Gastroenterol Nutr 2000 31 : 323 324.
31. Bayrakci US, Topaloglu R, Soylemezoglu O, Kalyoncu M, Ozen S, Besbas N, et al. Effect of early corticosteroid therapy on development of Henoch-Schönlein nephritis. J Nephrol 2007 20 : 406 409.
32. Mollica F, Li Volti S, Garozzo R, Russo G. Corticosteroid therapy does not prevent nephritis in Henoch-Schönlein purpura. Pediatr Nephrol 1994 8 : 131.
33. Islek I, Sezer T, Totan M, Cakir M, Kucukoduk S The effect of profilactic prednisolone therapy on renal involvement in Henoch Schoenlein vasculitis. 36th Congress. European Renal Association. European Dialysis and Transplantation Association, Madrid, Spain, 5-8 September, 1999 : 103 p.
34. Huber AM, King J, McLaine P, Klassen T, Pothos M. A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein purpura. BMC Med 2004 2 : 1 7.
35. Dudley J, Smith G, Lewellyn-Edwards A, Tizard EJ. Randomised placebo controlled trial to assess the role of early prednisolone on the development and progression of Henoch-Schonlein purpura nephritis. Pediatr Nephrol 2007 22 : 1457.
36. Peratoner L, Longo F, Lepore L, Freschi P. Prophylaxis and therapy of glomerulonephritis in the course of anaphylactoid purpura. The results of a polycentric clinical trial. Acta Paediatr Scand 1990 79 : 976 977.
37. Yoshimoto M, Ito Y, Shindo S, Yamashita F. Evaluation of the preventive role of dypyrydamole and aspirin against renal complication in Schonlein-Henoch purpura. Pediatr Nephrol 1987 1 : C47.
38. Yanyan H, Hongmei S, Lihua S, Min W Preventive value of heparin on the occurrence of nephropathy in Henoch-Schoenlein purpura: a randomized controlled clinical trial. 23rd International Congress of Paediatrics, September 9-14, Beijing, China, 2001.
39. Chartapisak W, Opastirakul S, Willis NS, Craig JC, Hodson EM. Prevention and treatment of renal disease in Henoch-Schonlein Purpura: a systematic review. Arch Dis Child 2009 94 : 132 137.
40. Wyatt RJ, Hogg RJ. Evidence-based assessment of treatment options for children with IgA nephropathies. Pediatr Nephrol 2001 16 : 156 167.
41. Zaffanello M, Brugnara M, Franchini M. Therapy for children with Henoch-Schonlein purpura nephritis: a systematic review. Sci World J 2007 7 : 20 30.
42. Zaffanello M, Fanos V Treatment based literature of Henoch-Schonlein purpura nephritis in childhood. Pediatr Nephrol 2008 doi :.
43. Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, et al. Prognosis of Henoch-Schönlein nephritis in children. Br Med J 1977 2 : 11 4.
44. Inoue CN, Chiba Y, Morimoto T, Nishio T, Kondo Y, Adachi M, et al. Tonsillectomy in the treatment of pediatric Henoch-Schönlein nephritis. Clin Nephrol 2007 67 : 298 305.
45. Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, et al. A placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA, nephropathy and moderate proteinuria. J Am Soc Nephrol 2007 18 : 1880 1888.
46. Tarshish P, Bernstein J, Edelmann CM. Henoch-Schonlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 2004 19 : 51 6.
47. Ronkainen J, ala-Houhala M, Antikainen M, Jahnukainen T, Koskimies O, Merenmeis J, et al. Cyclosporine A (CyA) versus MP pulses (MP) in the treatment of severe Henoch-Schonlein nephritis. Pediatr Nephrol 2006 21 : 1531.
48. Jauhola O, Ronkainen J, Ala-Houhala M, Autio-Harmainen H, Hoitta T, Jahnukainen T, et al. Cyclosporine A (CyA) versus MP pulses (MP) in severe Henoch-Schonlein nephritis (HSN): outcome after 2 year follow-up. Pediatr Nephrol 2008 23 : 1584.
49. Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol 1998 12 : 238 243.
50. Foster BJ, Bernard C, Drummond KN, Sharma AK. Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 2000 136 : 370 375.
51. Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S. Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 2003 18 : 347 350.
52. Shenoy M, Bradbury MG, Lewis MA, Webb NJ. Outcome of Henoch- Schönlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol 2007 22 : 1717 1722.
53. Ronkainen J, Autio-Harmainen H, Nuutinen M. Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis. Pediatr Nephrol 2003 18 : 1138 1142.
54. Shin JI, Park JM, Shin YH, Kim JH, Kim PK, Lee JS, et al. Cyclosporin A therapy for severe Henoch-Schonlein nephritis with nephrotic syndrome. Pediatr Nephrol 2005 20 : 1093 1097.
55. Oner A, Tinaztepe K, Erdogan O. The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis. Pediatr Nephrol 1995 9 : 6 10.
56. Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schonlein nephritis. Pediatrics 2003 111 : 785 789.
57. Shenoy M, Ognjanovic MV, Coulthard MG. Treating severe Henoch-Schönlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol 2007 22 : 1167 1171.
58. Gianviti A, Trompeter RS, Barratt TM, Lythgoe MF, Dillon MJ. Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis. Arch Dis Child 1996 75 : 186 190.
59. Appel AS, Appel GB. An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases. Nat Clin Pract Nephrol 2009 5 : 132 142.
60. Hogg RJ, Wyatt R, Scientific Planning Committee of the North American IgA Nephropathy Study. A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy. BMC Nephrol 2004 5 : 3.